Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Presents Phase 1b Clinical Data of IBI188 (Anti-CD47 Monoclonal Antibody) at the 2022 American Society of Hematology Annual Meeting 2022-12-11 08:00
Treadwell Therapeutics Announces A Presentation at the 2022 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor 2022-12-09 22:30
Innovent Presents Phase Ib Clinical Data of IBI939 (Anti-TIGIT Monoclonal Antibody) in Previously Untreated PD-L1-selected NSCLC at the 2022 European Society For Medical Oncology Immuno-Oncology Congress 2022-12-09 08:00
Innovent Presents Phase Ib Clinical Data Update of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 European Society For Medical Oncology Immuno-Oncology Congress 2022-12-09 08:00
SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France 2022-12-09 06:30
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA 2022-12-08 22:00
Createrna Announces Positive Top-Line Results from Phase 1 Clinical Trials of QR052107B Tablet in Healthy Volunteers 2022-12-08 14:29
Antengene Appoints Amily Zhang as its Chief Medical Officer 2022-12-08 08:30
Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by China NMPA 2022-12-07 18:10
Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood 2022-12-07 14:00
Apollo Proton Cancer Centre successfully performs Asia's 1st Brain Bypass Surgery on twin children with Moya Moya Disease 2022-12-07 13:17
Suvoda Launches eCOA-Specific Language and Design Toolkit as Solution Moves to Second Phase of Early Adopter Program 2022-12-07 08:00
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering 2022-12-07 07:00
Turn Biotechnologies Changes Paradigm in Skin Rejuvenation 2022-12-06 22:00
Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF) 2022-12-06 21:01
CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL 2022-12-06 20:04
Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030 2022-12-06 20:00
Clarivate Expands Real World Data and Analytics Solutions with Addition of U.S. Specialty Pharmacy Data 2022-12-06 18:20
GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS 2022-12-06 17:14
Meihua International Medical Technologies Co., Ltd. Appoints New CEO, CFO and Directors 2022-12-05 22:33
1 95 96 97 98 99 374